Table II.
Characteristics and type of infection present in females undergoing in vitro fertilization.
Factor | Overall (n=111) | Pregnant (n=32) | Non-pregnant (n=79) | P-value |
---|---|---|---|---|
Estradiol-2 levels (pg/ml) | 2234.38±1614.06 | 2853.75±1393.58 | 1983.49±1619.4 | 0.007 |
Retrieved oocytes (mean) | 4.9 | 6.13 | 6.3 | NS |
Fertilized oocytes (mean) | 4.26 | 5.31 | 4.41 | 0.002 |
Embryos (mean) | 2.56 | 2.63 | 3.84 | 0.004 |
Transferred embryos (mean) | 2.26 | 2.63 | 2.22 | 0.008 |
Male factor infertility (n) | 17 | 11 | 6 | NS |
Tubal factor infertility (n) | 39 | 6 | 6 | 0.0009 |
Endometriosis (n) | 9 | 2 | 33 | 0.028 |
Ovulation disorder (n) | 12 | 4 | 7 | NS |
Unexplained infertility (n) | 34 | 9 | 8 | NS |
Vaginal discharge samples | ||||
1 pathogen | 1 | 0 | 25 | NS |
2 pathogens | 10 | 4 | 1 | NS |
>2 pathogens | 100 | 28 | 6 | NS |
Mycoplasma species | 21 | 2 | 72 | NS |
Aerobic vaginitis | 14 | 4 | 19 | 0.03 |
Bacterial vaginosis | 41 | 10 | 10 | NS |
Candida species | 8 | 4 | 31 | NS |
CMV | 8 | 3 | 4 | NS |
HPV | 19 | 8 | 5 | NS |
HCV | 0 | 0 | 11 | NS |
HIV | 0 | 0 | 0 | NS |
HBV | 0 | 0 | 0 | NS |
Toxoplasma | 29 | 10 | 0 | NS |
Rubella | 96 | 27 | 19 | NS |
Chlamydia trachomatis | 9 | 3 | 69 | NS |
NS, not significant; CMV, cytomegalovirus; HPV, human papilloma virus; HCV, hepatitis C; HIV, human immunodeficiency virus; HBV, hepatitis B virus.